Paper39488602
Analysis of molecular mechanisms of delafloxacin resistance in Escherichia coli.
Kubicskó A and 3 others. Sci Rep, 2024. Cited by 9 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Analysis of molecular mechanisms of delafloxacin resistance in Escherichia coli. Papers, record 39488602. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39488602
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Escherichia coli | Major topic |
| Fluoroquinolones | Major topic |
| Microbial Sensitivity Tests | Major topic |
| Anti-Bacterial Agents | Major topic |
| Drug Resistance, Bacterial | Major topic |
| Mutation | |
| Whole Genome Sequencing | |
| Humans | |
| DNA Gyrase | |
| DNA Topoisomerase IV | |
| Escherichia coli Infections | |
| beta-Lactamases |
Source PubMed
Grants4
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| No "0272". | HUN-REN-SU Human Microbiota Research Group | PubMed | ||
| 952491-AmReSu | European Union's Horizon 2020 research and innovation program | PubMed | ||
| 952491-AmReSu | European Union's Horizon 2020 research and innovation program | PubMed | ||
| János Bolyai Research Scholarship (BO/00286/22/5) | Hungarian Academy of Sciences | PubMed |
Source PubMed
References60
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 27,215,369 | Chemical structure and pharmacokinetics of novel quinolone agents represented by avarofloxacin, delafloxacin, finafloxacin, zabofloxacin and nemonoxacin. | Ann Clin Microbiol Antimicrob | 2016 | https://conductscience.org/library/papers/27215369 | PubMed |
| 2 | 36,459,132 | Distribution of virulence determinants among Escherichia coli ST131 and its H30/H30-Rx subclones in Turkey. | Acta Microbiol Immunol Hung | 2023 | https://conductscience.org/library/papers/36459132 | PubMed |
| 3 | 32,152,527 | Antibiotics in the clinical pipeline in October 2019. | J Antibiot (Tokyo) | 2020 | https://conductscience.org/library/papers/32152527 | PubMed |
| 4 | 38,667,039 | Genomic Epidemiology of C2/H30Rx and C1-M27 Subclades of Escherichia coli ST131 Isolates from Clinical Blood Samples in Hungary. | Antibiotics (Basel) | 2024 | https://conductscience.org/library/papers/38667039 | PubMed |
| 5 | 12,812,718 | Detection of mutations in quinolone resistance-determining regions in levofloxacin- and methicillin-resistant Staphylococcus aureus: effects of the mutations on fluoroquinolone MICs. | Diagn Microbiol Infect Dis | 2003 | https://conductscience.org/library/papers/12812718 | PubMed |
| 6 | 37,887,221 | Emergence and Genomic Features of a mcr-1 Escherichia coli from Duck in Hungary. | Antibiotics (Basel) | 2023 | https://conductscience.org/library/papers/37887221 | PubMed |
| 7 | 38,622,998 | High-risk Escherichia coli clones that cause neonatal meningitis and association with recrudescent infection. | Elife | 2024 | https://conductscience.org/library/papers/38622998 | PubMed |
| 8 | 36,556,442 | Emergence and Dissemination of Extraintestinal Pathogenic High-Risk International Clones of Escherichia coli. | Life (Basel) | 2022 | https://conductscience.org/library/papers/36556442 | PubMed |
| 9 | 38,318,209 | Whole-Genome Sequencing of an Escherichia coli ST69 Strain Harboring blaCTX-M-27 on a Hybrid Plasmid. | Infect Drug Resist | 2024 | https://conductscience.org/library/papers/38318209 | PubMed |
| 10 | 29,250,038 | Double-Serine Fluoroquinolone Resistance Mutations Advance Major International Clones and Lineages of Various Multi-Drug Resistant Bacteria. | Front Microbiol | 2017 | https://conductscience.org/library/papers/29250038 | PubMed |
| 11 | 35,710,924 | The impact of the ST131 clone on recurrent ESBL-producing E. coli urinary tract infection: a prospective comparative study. | Sci Rep | 2022 | https://conductscience.org/library/papers/35710924 | PubMed |
| 12 | 37,375,104 | Investigation of Delafloxacin Resistance in Multidrug-Resistant Escherichia coli Strains and the Detection of E. coli ST43 International High-Risk Clone. | Microorganisms | 2023 | https://conductscience.org/library/papers/37375104 | PubMed |
| 13 | 39,126,340 | In vitro activity of delafloxacin against clinical levofloxacin-resistant Helicobacter pylori isolates. | J Antimicrob Chemother | 2024 | https://conductscience.org/library/papers/39126340 | PubMed |
| 14 | 31,916,915 | Characterization of O25b-ST131 Escherichia coli Clone Producing CTX-M-15, DHA-4, and CMY-42 in Urinary Tract Infections in a Tunisian Island. | Microb Drug Resist | 2020 | https://conductscience.org/library/papers/31916915 | PubMed |
| 15 | 35,095,799 | Comparison of Extended-Spectrum Beta-Lactamase-Producing Escherichia coli Isolates From Rooks (Corvus frugilegus) and Contemporary Human-Derived Strains: A One Health Perspective. | Front Microbiol | 2021 | https://conductscience.org/library/papers/35095799 | PubMed |
| 16 | 28,167,542 | In Vitro Activity of Delafloxacin against Contemporary Bacterial Pathogens from the United States and Europe, 2014. | Antimicrob Agents Chemother | 2017 | https://conductscience.org/library/papers/28167542 | PubMed |
| 17 | 23,827,749 | Characterization of extended-spectrum β-lactamase (ESBL) producing Escherichia coli strains isolated from animal and human clinical samples in Hungary in 2006-2007. | Acta Microbiol Immunol Hung | 2013 | https://conductscience.org/library/papers/23827749 | PubMed |
| 18 | 34,097,486 | Identification of qnrE3 and qnrE4, New Transferable Quinolone Resistance qnrE Family Genes Originating from Enterobacter mori and Enterobacter asburiae, Respectively. | Antimicrob Agents Chemother | 2021 | https://conductscience.org/library/papers/34097486 | PubMed |
| 19 | 38,319,508 | Reduced susceptibility to aztreonam-avibactam conferred by acquired AmpC-type β-lactamases in PBP3-modified Escherichia coli. | Eur J Clin Microbiol Infect Dis | 2024 | https://conductscience.org/library/papers/38319508 | PubMed |
| 20 | 36,363,736 | Dissemination of High-Risk Clones Enterobacterales among Bulgarian Fecal Carriage Isolates. | Microorganisms | 2022 | https://conductscience.org/library/papers/36363736 | PubMed |
Cited by8
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 9 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42,864,405 | Efflux modulation as an antimicrobial strategy: mechanisms and translational perspectives. | NPJ Drug Discov | 2026 | https://conductscience.org/library/papers/42864405 | PubMed |
| 42,635,419 | In vitro activity of delafloxacin against enterococcal isolates from male urinary tract infections and genetic determinants of resistance. | Microbiol Spectr | 2026 | https://conductscience.org/library/papers/42635419 | PubMed |
| 41,811,471 | Delafloxacin: what does a new fluoroquinolone offer? | Rev Esp Quimioter | 2026 | https://conductscience.org/library/papers/41811471 | PubMed |
| 41,608,681 | Molecular resistance mechanisms to newly approved antibiotics (2017-2025) in WHO priority pathogens. | Front Microbiol | 2025 | https://conductscience.org/library/papers/41608681 | PubMed |
| 41,070,133 | Analysis of the microbial spectrum of urinary tract infections and antibiotic resistance of UPEC in Central Inner Mongolia, China. | Front Microbiol | 2025 | https://conductscience.org/library/papers/41070133 | PubMed |
| 40,836,876 | Molecular characterization of fluoroquinolone resistance in invasive clinical isolates of Streptococcus pneumoniae susceptible to delafloxacin. | J Antimicrob Chemother | 2025 | https://conductscience.org/library/papers/40836876 | PubMed |
| 40,558,132 | Variable In Vitro Efficacy of Delafloxacin on Multidrug-Resistant Pseudomonas aeruginosa and the Detection of Delafloxacin Resistance Determinants. | Antibiotics (Basel) | 2025 | https://conductscience.org/library/papers/40558132 | PubMed |
| 39,858,348 | Detection of Delafloxacin Resistance Mechanisms in Multidrug-Resistant Klebsiella pneumoniae. | Antibiotics (Basel) | 2025 | https://conductscience.org/library/papers/39858348 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39488602
GET https://conductscience.org/api/papers/v1/39488602/references?page=2